First author | Year | Country | Male | Sample size | Age (years) | bDefinitions of sarcopenia | Follow-up durations | Result of effect size | Outcome | Qualitya |
---|---|---|---|---|---|---|---|---|---|---|
P.M Cawthon | 2017 | USA | 100% | 1516 | 70–80 | EWGSOP | 3 years | OR:1.27 (0.85, 1.90) | hospitalization | 7 |
S.Gariballa | 2013 | UK | 74.30% | 432 | 70–80 | EWGSOP | 0.5 years | HR:2.52(1.34,4.74) | re-hospitalization | 6 |
L.Bianchi | 2016 | Italy | 46.80% | 538 | 77.1 | EWGSOP | 10 years | HR:1.57(1.03,2.41) | hospitalization | 7 |
T.Henwood | 2017 | Australia | 29.30% | 58 | 80–90 | EWGSOP | 1.5 years | RR:1.27(0.73,2.22) | hospitalization | 6 |
M.Yang | 2017 | China | 78.10% | 288 | 81.1 ± 6.6 | AWGS | 3 years | HR:1.81(1.17,2.80) | re-hospitalization | 8 |